APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 323 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $284,961 | +27.9% | 3,128 | -7.4% | 0.16% | +19.6% |
| Q1 2023 | $222,813 | -24.7% | 3,378 | -41.0% | 0.14% | -31.7% |
| Q4 2022 | $296,040 | -89.5% | 5,725 | -86.2% | 0.20% | -89.6% |
| Q3 2022 | $2,825,000 | +769.2% | 41,365 | +476.2% | 1.94% | +742.0% |
| Q2 2022 | $325,000 | -7.1% | 7,179 | +4.4% | 0.23% | +4.1% |
| Q1 2022 | $350,000 | -38.6% | 6,879 | -43.0% | 0.22% | -36.6% |
| Q4 2021 | $570,000 | +172.7% | 12,060 | +264.4% | 0.35% | +171.3% |
| Q2 2021 | $209,000 | -11.8% | 3,310 | -40.1% | 0.13% | -15.7% |
| Q1 2021 | $237,000 | -27.5% | 5,523 | -3.4% | 0.15% | -31.7% |
| Q4 2020 | $327,000 | – | 5,718 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |